| Literature DB >> 16944917 |
Abstract
Analysis of peptides in biological fluids by mass spectrometry holds promise of providing diagnostic and prognostic information for cancer and other diseases. Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16944917 DOI: 10.1021/pr060225u
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466